Logo image of PRE.MI

PREDICT SPA (PRE.MI) Stock Fundamental Analysis

BIT:PRE - IT0005611071 - Common Stock

0.875 EUR
+0.01 (+1.16%)
Last: 9/1/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PRE. PRE was compared to 27 industry peers in the Health Care Providers & Services industry. While PRE has a great health rating, its profitability is only average at the moment. PRE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

PRE had positive earnings in the past year.
PRE.MI Yearly Net Income VS EBIT VS OCF VS FCFPRE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

The Return On Assets of PRE (7.11%) is better than 88.89% of its industry peers.
PRE has a Return On Equity of 16.48%. This is amongst the best in the industry. PRE outperforms 81.48% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.60%, PRE belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.
Industry RankSector Rank
ROA 7.11%
ROE 16.48%
ROIC 14.6%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PRE.MI Yearly ROA, ROE, ROICPRE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2 4 6

1.3 Margins

The Profit Margin of PRE (5.07%) is better than 85.19% of its industry peers.
PRE has a better Operating Margin (7.76%) than 62.96% of its industry peers.
The Gross Margin of PRE (20.96%) is worse than 62.96% of its industry peers.
Industry RankSector Rank
OM 7.76%
PM (TTM) 5.07%
GM 20.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PRE.MI Yearly Profit, Operating, Gross MarginsPRE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15 20

More info and screens

7

2. Health

2.1 Basic Checks

PRE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
There is no outstanding debt for PRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRE.MI Yearly Shares OutstandingPRE.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M 4M 5M
PRE.MI Yearly Total Debt VS Total AssetsPRE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

An Altman-Z score of 3.59 indicates that PRE is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 3.59, PRE belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
There is no outstanding debt for PRE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.59
ROIC/WACC1.89
WACC7.72%
PRE.MI Yearly LT Debt VS Equity VS FCFPRE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 1M -1M 2M

2.3 Liquidity

PRE has a Current Ratio of 1.27. This is a normal value and indicates that PRE is financially healthy and should not expect problems in meeting its short term obligations.
PRE's Current ratio of 1.27 is in line compared to the rest of the industry. PRE outperforms 59.26% of its industry peers.
PRE has a Quick Ratio of 1.27. This is a bad value and indicates that PRE is not financially healthy enough and could expect problems in meeting its short term obligations.
PRE's Quick ratio of 0.90 is in line compared to the rest of the industry. PRE outperforms 48.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.9
PRE.MI Yearly Current Assets VS Current LiabilitesPRE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

1

3. Growth

3.1 Past

PRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.14%, which is quite impressive.
The Revenue has decreased by -7.84% in the past year.
EPS 1Y (TTM)76.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1757.14%
Revenue 1Y (TTM)-7.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-46.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRE.MI Yearly Revenue VS EstimatesPRE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.58, which indicates a correct valuation of PRE.
Compared to the rest of the industry, the Price/Earnings ratio of PRE indicates a somewhat cheap valuation: PRE is cheaper than 66.67% of the companies listed in the same industry.
PRE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.03.
Industry RankSector Rank
PE 14.58
Fwd PE N/A
PRE.MI Price Earnings VS Forward Price EarningsPRE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRE.MI Per share dataPRE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PREDICT SPA

BIT:PRE (9/1/2025, 7:00:00 PM)

0.875

+0.01 (+1.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.87M
Analysts80
Price Target1.94 (121.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.58
Fwd PE N/A
P/S 0.74
P/FCF N/A
P/OCF N/A
P/B 2.39
P/tB 3.02
EV/EBITDA N/A
EPS(TTM)0.06
EY6.86%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.19
BVpS0.37
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.11%
ROE 16.48%
ROCE 21.65%
ROIC 14.6%
ROICexc 16.05%
ROICexgc 19.99%
OM 7.76%
PM (TTM) 5.07%
GM 20.96%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 0.9
Altman-Z 3.59
F-ScoreN/A
WACC7.72%
ROIC/WACC1.89
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1757.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-46.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A